However, inhibitors of DPP4 increase the availability of endogenous circulating GLP-1 and GIP, and stable incretin hormone analogues as well as the GLP-1 mimetic exendin-4 have successfully been employed in diabetes treatment. Here, GCG is linked to diabetes mellitus.